External beam radiotherapy for prostate cancer: Urinary outcomes for men with high International Prostate Symptom Scores (IPSS)

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 4, 2011, Pages 1080-1086

  Malik, Renuka ^a   Jani, Ashesh B ^b   Liauw, Stanley L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

External beam radiotherapy; Genitourinary toxicity; IPSS

Indexed keywords

ACUTE GU TOXICITY; EXTERNAL BEAM RADIOTHERAPY; GENITOURINARY TOXICITIES; INTERNATIONAL PROSTATE SYMPTOM SCORES; IPSS; LOCALIZED PROSTATE CANCER; PRE-TREATMENT; PROSTATE CANCERS; RADIATION THERAPY ONCOLOGY GROUPS; URINARY FUNCTIONS; URINARY SYMPTOMS;

DISEASES; TOXICITY;

RADIOTHERAPY;

GONADOTROPIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ANDROGEN DEPRIVATION THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONFERENCE PAPER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RADIATION INJURY; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; URINARY TRACT OBSTRUCTION; UROGENITAL TRACT DISEASE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROSTATISM; RADIOTHERAPY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; URINARY RETENTION; URINATION DISORDERS;

EID: 79959330027     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.03.040     Document Type: Conference Paper

References (36)

1. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557 discussion 1564
2. J. Bucci, W.J. Morris, and M. Keyes Predictive factors of urinary retention following prostate brachytherapy Int J Radiat Oncol Biol Phys 53 2002 91 98 (Pubitemid 34465811)
3. N.J. Mabjeesh, J. Chen, and A. Stenger Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy Urology 70 2007 548 553 (Pubitemid 47464503)
4. M.D. Terk, R.G. Stock, and N.N. Stone Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1998 1379 1382 (Pubitemid 29480520)
5. M. Keyes, S. Miller, and V. Moravan Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients Int J Radiat Oncol Biol Phys 73 2009 1023 1032
6. J.A. Cesaretti, N.N. Stone, and R.G. Stock Urinary symptom flare following I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 56 2003 1085 1092 (Pubitemid 36794042)
7. T. Ohashi, A. Yorozu, and K. Toya Serial changes of international prostate symptom score following I-125 prostate brachytherapy Int J Clin Oncol 11 2006 320 325 (Pubitemid 44306217)
8. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799 (Pubitemid 29284127)
9. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
10. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261 (Pubitemid 351439226)
11. D. Slova, and H. Lepor The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms J Urol 178 2007 2397 2400 discussion 2400-2391
12. M.S. Litwin, J.L. Gore, and L. Kwan Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer Cancer 109 2007 2239 2247 (Pubitemid 46801553)
13. A.L. Potosky, J. Legler, and P.C. Albertsen Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study J Natl Cancer Inst 92 2000 1582 1592
14. C.L. Shrader-Bogen, J.L. Kjellberg, and C.P. McPherson Quality of life and treatment outcomes: Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy Cancer 79 1997 1977 1986 (Pubitemid 27200383)
15. J.A. Talcott, J. Manola, and J.A. Clark Time course and predictors of symptoms after primary prostate cancer therapy J Clin Oncol 21 2003 3979 3986 (Pubitemid 46606212)
16. J. Mohler, R.J. Babaian, and R.R. Bahnson Prostate cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 5 2007 650 683
17. S.L. Liauw, R.R. Weichselbaum, and C. Rash Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer Technol Cancer Res Treat 8 2009 201 206
18. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181 (Pubitemid 36962641)
19. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
20. D.M. Herold, A.L. Hanlon, and G.E. Hanks Diabetes mellitus: A predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 1999 475 479 (Pubitemid 29107163)
21. T.E. Schultheiss, W.R. Lee, and M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11 (Pubitemid 27090129)
22. A. Harsolia, C. Vargas, and D. Yan Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: Dose-volume analysis of a phase II dose-escalation study Int J Radiat Oncol Biol Phys 69 2007 1100 1109 (Pubitemid 47625853)
23. M. Liu, T. Pickles, and E. Berthelet Urinary incontinence in prostate cancer patients treated with external beam radiotherapy Radiother Oncol 74 2005 197 201 (Pubitemid 40331877)
24. S.T. Peeters, W.D. Heemsbergen, and W.L. van Putten Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy Int J Radiat Oncol Biol Phys 61 2005 1019 1034 (Pubitemid 40340897)
25. M.R. Cheung, S.L. Tucker, and L. Dong Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 67 2007 1059 1065
26. R.K. Valicenti, K. Winter, and J.D. Cox RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 2003 614 620 (Pubitemid 37194286)
27. M.J. Zelefsky, D. Cowen, and Z. Fuks Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 1999 2460 2468 (Pubitemid 29244857)
28. S.J. Feigenberg, A.L. Hanlon, and E.M. Horwitz Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 62 2005 397 405 (Pubitemid 40704456)
29. G. Borghede, and H. Hedelin Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study Radiother Oncol 43 1997 139 146 (Pubitemid 27261582)
30. A. Karlsdottir, D.C. Johannessen, and L.P. Muren Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer Radiother Oncol 71 2004 43 53 (Pubitemid 38452901)
31. J.F. Langenhuijsen, E.N. van Lin, and A.L. Hoffmann Neoadjuvant androgen deprivation for prostate volume reduction: The optimal duration in prostate cancer radiotherapy Urol Oncol 2009 In press
32. W. Lilleby, S.D. Fossa, and B.H. Knutsen Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation Radiother Oncol 57 2000 195 200
33. C.M. Zechmann, K. Aftab, and B. Didinger Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy - A follow-up study Radiother Oncol 90 2009 408 412
34. M.J. Zelefsky, R.X. Ginor, and Z. Fuks Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 45 1999 567 570 (Pubitemid 29462634)
35. S. Lehrer, N.N. Stone, and M.J. Droller Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer Urol Oncol 7 2002 73 76
36. M. Saitoh, E. Ramirez, and R.J. Babaian Ultrasonic volume monitoring in patient with prostate cancer treated by external beam radiation therapy Urology 43 1994 342 348 (Pubitemid 24111431)